ArticleKidney international reports2026
Impact of Cold Ischemia Time on Allograft Survival and Policy.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Changes in national allocation policy and regulatory practices have led to increases in cold ischemia time (CIT) and out-of-sequence allocation (AOOS) or expedited placement (EP) of deceased donor kidney transplants in the United States. The aims of this study were to gauge the clinical relevance of the increased CIT that accompanied kidney allocation system (KAS) 250 NM (KAS250), and to measure CIT for AOOS or EP kidneys. Methods: The United Network for Organ Sharing (UNOS) data from 2007 to 2023 were analyzed across pre-KAS, KAS, and KAS250 eras. The impact of CIT on kidney graft survival and the CIT of kidneys undergoing AOOS or EP during these eras was assessed. Results: Median CIT increased from 16 hours to 19.6 hours, and the incidence of AOOS or EP increased from 0.5% to 13%. Transplants with CIT of 32 to 36 hours had a 10% increase in overall graft loss compared with CIT of 16 to 20 hours ( Conclusion: Current allocation practices do not prioritize CIT. Extended CIT is associated with inferior long-term graft survival. AOOS or EP is designed to prevent discards but does not currently target high KDPI kidneys. Our data provide a framework to assess the relative importance of CIT in allocation policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.